Skip to content
Trial Eligibility
Menu

Evaluation of the SMART IBD App in Pediatric IBD

NCT07195123

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Inflammatory Bowel Disease (IBD)
  • IBD (Inflammatory Bowel Disease)
  • IBD - Inflammatory Bowel Disease
  • Ulcerative Colitis (UC)
  • Indeterminate Colitis
  • Crohn Disease (CD)
  • IBD

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
13 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Children's Hospital Medical Center, Cincinnati
Last updated on ClinicalTrials.gov
November 21, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Ohio · 1

  • Cincinnati Children's Hospital Medical Center · Cincinnati, OH

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.